Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G6QL
|
||||
Former ID |
DNC005726
|
||||
Drug Name |
1-Naphthalen-2-yl-1H-imidazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527801] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H10N2
|
||||
Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)N3C=CN=C3
|
||||
InChI |
1S/C13H10N2/c1-2-4-12-9-13(6-5-11(12)3-1)15-8-7-14-10-15/h1-10H
|
||||
InChIKey |
LHAAPZJTEBPKBJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [527801] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527801] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen MetabolismPW000141:Steroidogenesis | ||||
WikiPathways | Metapathway biotransformation | ||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Ovarian Infertility Genes | |||||
Metabolism of steroid hormones and vitamin D | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.